0G99

Thrombogenics Nv News

Company Name Stock Ticker Symbol Market Type
Thrombogenics Nv 0G99 London Ordinary Share
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 4.88 20:00:00
Open Price Low Price High Price Close Price Prev Close
4.88
more quote information »

Recent News

Date Time Source Heading
9/30/202213:00GLOBEInformation on the Total Number of Voting Rights..
9/12/202213:00GLOBEOxurion To Participate in Upcoming Scientific and Investor..
9/07/202202:25GLOBEOxurion Publishes First Half 2022 Results
9/02/202217:00GLOBEOxurion Announces Amendment to Funding Program with Negma..
8/26/202213:00GLOBEInformation on the Total Number of Voting Rights..
8/24/202213:00GLOBEOxurion To Present at Upcoming Scientific and Investor..
7/29/202213:00GLOBEInformation on the Total Number of Voting Rights..
7/11/202213:00GLOBEOxurion Announces Presentations at Upcoming Scientific and..
6/30/202214:00GLOBEInformation on the Total Number of Voting Rights..
6/13/202213:00GLOBEOxurion Announces Two Presentations at The Macula Society..
6/07/202213:00GLOBEOxurion Announces Preclinical Presentation on THR-149 at..
6/03/202202:00GLOBEOxurion Announces Two Upcoming Presentations at The Macula..
6/01/202213:15GLOBEOxurion to Participate in Upcoming Investor Conferences
5/31/202213:00GLOBEInformation on the Total Number of Voting Rights..
5/25/202213:00GLOBEOxurion Announces Results of the Extraordinary Shareholders’..
5/24/202213:00GLOBEOxurion Announces Upcoming Preclinical Presentation on ..
5/09/202202:30GLOBEOxurion Announces Top-Line Results from Part A of Phase 2..
4/11/202201:00GLOBEOxurion Announces Upcoming Pre-Clinical Data Presentation on..
4/01/202213:00GLOBEOxurion Announces Extraordinary and Annual Shareholders’..
3/30/202213:00GLOBEInformation on the Total Number of Voting Rights..
3/28/202202:00GLOBEOxurion to Participate in Needham Virtual Healthcare..
3/25/202217:11GLOBEOxurion Publishes 2021 Annual Report
3/17/202214:00GLOBEOxurion Receives Transparency Notifications from Fidelity..
3/07/202204:00GLOBEOxurion Successfully Closes EUR >10 Million in Private..
3/03/202206:15GLOBEOXURION SUCCESSFULLY RAISES EUR >10 MILLION FROM LEADING US..
3/03/202202:00GLOBEOXURION SUCCESSFULLY RAISES EUR >10 MILLION FROM LEADING US..
2/22/202202:01GLOBEInformation on the Total Number of Voting Rights..
2/22/202202:00GLOBEOxurion NV announces 2021 Full Year Results and 2022 Outlook
2/14/202202:00GLOBEOxurion Announces New Data on THR-149 Phase 2 Clinical Trial..
2/11/202202:00GLOBEOxurion Announces Upcoming Presentation on THR-149 Phase 2..
2/08/202202:00GLOBEOxurion to Participate in the 2022 BIO CEO and Investor..
1/18/202202:00GLOBEOXURION to Participate in the 10th edition of Degroof..
1/07/202201:00GLOBEOxurion Provides Update on Clinical Pipeline Progress
1/04/202212:00GLOBEOXURION to Present at the H.C. Wainwright BioConnect 2022..
11/30/202101:00GLOBEInformation on the Total Number of Voting Rights..
11/24/202101:30GLOBEOXURION to Present at the Ophthalmology Day at BTIG
11/22/202101:00GLOBEOXURION NV Secures EUR 10 Million Convertible Bond Financing..
11/15/202101:00GLOBEOXURION NV - First Patient Dosed in Part B of Phase 2..
11/04/202102:00GLOBEOxurion NV Announces Initiation of Equity Analyst Coverage..
10/13/202101:00GLOBEOxurion NV Announces First Patient Dosed in its Phase 2..
10/11/202101:00GLOBEOXURION - Positive Phase 2 Part A THR-149 data shared at the..


Your Recent History
LSE
0G99
Thrombogen..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now